[HTML][HTML] Fluorouracil therapy and DPYD genotype

L Dean, M Kane - 2021 - europepmc.org
Fluorouracil, or 5-flourouracil (5-FU), is a chemotherapy agent that belongs to the drug class
of fluoropyrimidines. When given as an intravenous (IV) solution, 5-FU is used in the …

[HTML][HTML] Capecitabine therapy and DPYD genotype

L Dean, M Kane - 2020 - europepmc.org
Capecitabine (brand name Xeloda) is a chemotherapy agent that belongs to the drug class
of fluoropyrimidines. It is widely used in the treatment of several malignancies including …

Synthesis and in vitro characterization of PCL-PEG-HA/FeCo magnetic nanoparticles encapsulating curcumin and 5-FU.

S Bourang, M Noruzpour, S Azizi… - Nanomedicine …, 2024 - search.ebscohost.com
Objective (s): Colorectal cancer is the second deadly cancer for men and women worldwide.
Depending on the pathological attributes of the tumor, there are numerous therapeutic …

[PDF][PDF] Role of microRNAs in fluoropyrimidine-related toxicity: what we know.

AL Deac, CC Burz, C Militaru… - European Review for …, 2021 - europeanreview.org
Although more than half a century has passed since the discovery of fluoropyrimidines, they
are still used in the treatment of many types of cancer, and it is estimated that annually two …

Introducing a simple and cost-effective RT-PCR protocol for detection of DPYD*2A polymorphism: the first study in Kurdish population

M Salmani, B Ghaderi, A Fotoohi… - Cancer Chemotherapy …, 2022 - Springer
Purpose Fluoropyrimidines, the major chemotherapeutic agents in various malignancies
treatment, are metabolized by dihydropyrimidine dehydrogenase (DPD). DPD deficiency …

Polymorphism in thymidylate synthase gene predicts survival and toxicity in north indian lung cancer patients undergoing platinum-based doublet chemotherapy

P Sharma, N Singh, S Sharma - Oncology, 2022 - karger.com
Background: With an estimated 1.8 million deaths, lung cancer is one of the widely reported
malignancies, with substantial morbidity and mortality rates. Thymidylate synthase (TS) is an …

[PDF][PDF] Genetic polymorphisms associated with toxicity in treatment with 5-fluorouracil in patients with colorectal cancer: a systematic review

CA Tutillo, MG Pinos, MR Castro - Rev Oncol Ecu, 2022 - docs.bvsalud.org
In troduction: Colorectal cancer is the most common malignancy of the digestive tract. The
treatment is based on administering antitumor medications, such as 5-fluorouracil (5-FU) …

Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity

E Pozzi, P Alberti - Pharmacogenomics in Drug Discovery and …, 2022 - Springer
Pharmacogenomics is a powerful tool to predict individual response to treatment, in order to
personalize therapy, and it has been explored extensively in oncology practice. Not only …

Methylenetetrahydrofolate reductase C677T (rs1801133) polymorphism and pemetrexed treatment outcome in patients with non–small-cell lung cancer

MH Abbasian, N Ansarinejad, T Ramim… - Personalized Medicine …, 2021 - pmjournal.ir
Background: Lung cancer is the first cause of cancer deaths in the world. Pemetrexed is an
antifolate drug used as a first or second-line in the treatment of advanced non-small cell lung …

[HTML][HTML] Association between 5'-UTR and 3'-UTR Polymorphisms of the TYMS Gene and Breast Cancer in Kurdish Women of Iraq

KS Mohamad - Asian Pacific Journal of Cancer Prevention: APJCP, 2021 - ncbi.nlm.nih.gov
Breast cancer is a common cancer found among women worldwide. Many polymorphisms
can play a role in the development of this disease. The study was conducted to evaluate …